5. 2) samt tenofovirs og emtricitabins lange intracellulære halveringstid tages med i overvejelserne.
If therapy with Atripla is discontinued, consideration should be given to the long half-life of efavirenz (see section 5.2) and long intracellular half-lives of tenofovir and emtricitabine.